相似文献
1
GPCR ligand-dendrimer (GLiDe) conjugates: future smart drugs?
Trends Pharmacol Sci. 2010 Dec;31(12):575-9. doi: 10.1016/j.tips.2010.09.002. Epub 2010 Oct 18.
2
GPCR ligand dendrimer (GLiDe) conjugates: adenosine receptor interactions of a series of multivalent xanthine antagonists.
Bioconjug Chem. 2011 Jun 15;22(6):1115-27. doi: 10.1021/bc1005812. Epub 2011 May 12.
3
PEGylated dendritic unimolecular micelles as versatile carriers for ligands of G protein-coupled receptors.
Bioconjug Chem. 2009 Oct 21;20(10):1888-98. doi: 10.1021/bc9001689. Epub 2009 Sep 28.
4
Polyamidoamine (PAMAM) dendrimer conjugates of "clickable" agonists of the A3 adenosine receptor and coactivation of the P2Y14 receptor by a tethered nucleotide.
Bioconjug Chem. 2010 Feb 17;21(2):372-84. doi: 10.1021/bc900473v.
5
Enhanced potency of nucleotide-dendrimer conjugates as agonists of the P2Y14 receptor: multivalent effect in G protein-coupled receptor recognition.
Bioconjug Chem. 2009 Aug 19;20(8):1650-9. doi: 10.1021/bc900206g. Epub 2009 Jul 2.
6
Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats.
J Control Release. 2011 Jan 5;149(1):21-8. doi: 10.1016/j.jconrel.2010.02.017. Epub 2010 Feb 22.
7
Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).
Bioconjug Chem. 2009 Oct 21;20(10):1816-35. doi: 10.1021/bc9000596. Epub 2009 Apr 30.
8
Ligand Accessibility and Bioactivity of a Hormone-Dendrimer Conjugate Depend on pH and pH History.
J Am Chem Soc. 2015 Aug 19;137(32):10326-35. doi: 10.1021/jacs.5b05952. Epub 2015 Aug 10.
9
Comparison of generation 3 polyamidoamine dendrimer and generation 4 polypropylenimine dendrimer on drug loading, complex structure, release behavior, and cytotoxicity.
Int J Nanomedicine. 2011;6:3361-72. doi: 10.2147/IJN.S27028. Epub 2011 Dec 16.
10
Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity.
Bioconjug Chem. 2008 Aug;19(8):1660-72. doi: 10.1021/bc700483s. Epub 2008 Jul 9.
引用本文的文献
1
Application of Nanoparticles for Targeting G Protein-Coupled Receptors.
Int J Mol Sci. 2018 Jul 10;19(7):2006. doi: 10.3390/ijms19072006.
2
Drug conjugates-an emerging approach to treat breast cancer.
Pharmacol Res Perspect. 2018 Jul 5;6(4):e00417. doi: 10.1002/prp2.417. eCollection 2018 Jul.
3
Programmable nanoscaffolds that control ligand display to a G-protein-coupled receptor in membranes to allow dissection of multivalent effects.
J Am Chem Soc. 2014 Sep 3;136(35):12296-303. doi: 10.1021/ja504288s. Epub 2014 Aug 25.
4
Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates.
J Med Chem. 2013 May 23;56(10):3749-67. doi: 10.1021/jm400422s. Epub 2013 May 9.
5
Click modification in the N6 region of A3 adenosine receptor-selective carbocyclic nucleosides for dendrimeric tethering that preserves pharmacophore recognition.
Bioconjug Chem. 2012 Feb 15;23(2):232-47. doi: 10.1021/bc200526c. Epub 2012 Jan 11.
6
Anti-ischemic effects of multivalent dendrimeric A₃ adenosine receptor agonists in cultured cardiomyocytes and in the isolated rat heart.
Pharmacol Res. 2012 Mar;65(3):338-46. doi: 10.1016/j.phrs.2011.11.013. Epub 2011 Dec 1.
7
GPCR ligand dendrimer (GLiDe) conjugates: adenosine receptor interactions of a series of multivalent xanthine antagonists.
Bioconjug Chem. 2011 Jun 15;22(6):1115-27. doi: 10.1021/bc1005812. Epub 2011 May 12.
8
Molecular probes for the A2A adenosine receptor based on a pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine scaffold.
Bioorg Med Chem Lett. 2011 May 1;21(9):2740-5. doi: 10.1016/j.bmcl.2010.11.082. Epub 2010 Nov 21.
本文引用的文献
1
Functionalized congeners of P2Y1 receptor antagonists: 2-alkynyl (N)-methanocarba 2'-deoxyadenosine 3',5'-bisphosphate analogues and conjugation to a polyamidoamine (PAMAM) dendrimer carrier.
Bioconjug Chem. 2010 Jul 21;21(7):1190-205. doi: 10.1021/bc900569u.
2
Structure-based discovery of A2A adenosine receptor ligands.
J Med Chem. 2010 May 13;53(9):3748-55. doi: 10.1021/jm100240h.
3
Dendrimer internalization and intracellular trafficking in living cells.
Mol Pharm. 2010 Jun 7;7(3):680-8. doi: 10.1021/mp9002464.
4
Multivalent dendrimeric and monomeric adenosine agonists attenuate cell death in HL-1 mouse cardiomyocytes expressing the A(3) receptor.
Biochem Pharmacol. 2010 Jul 15;80(2):188-96. doi: 10.1016/j.bcp.2010.03.020. Epub 2010 Mar 25.
5
Polyamidoamine (PAMAM) dendrimer conjugates of "clickable" agonists of the A3 adenosine receptor and coactivation of the P2Y14 receptor by a tethered nucleotide.
Bioconjug Chem. 2010 Feb 17;21(2):372-84. doi: 10.1021/bc900473v.
6
Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications.
Drug Discov Today. 2010 Mar;15(5-6):171-85. doi: 10.1016/j.drudis.2010.01.009. Epub 2010 Jan 29.
7
Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.
J Med Chem. 2010 Feb 25;53(4):1799-809. doi: 10.1021/jm901647p.
8
Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.
Chem Rev. 2010 May 12;110(5):2921-59. doi: 10.1021/cr900232t.
9
Prodrug approaches for enhancing the bioavailability of drugs with low solubility.
Chem Biodivers. 2009 Nov;6(11):2071-83. doi: 10.1002/cbdv.200900114.
10
UDP-glucose acting at P2Y14 receptors is a mediator of mast cell degranulation.
Biochem Pharmacol. 2010 Mar 15;79(6):873-9. doi: 10.1016/j.bcp.2009.10.024. Epub 2009 Nov 5.
Zotero 插件